The novel coronavirus, now designated SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), was identified in Wuhan, Hubei province, China, on the 7th January 2020. This specific coronavirus causes the disease COVID-19, and there have been unofficial reports of confirmed cases going back to 17th November 2019. Subsequently, the world has seen a race to identify which medications could stop or alleviate the symptoms from this highly infectious disease.
A few weeks ago a colleague of mine living in Wuhan, China, was tested positive for the disease COVID-19, and spent 20 days quarantined in an emergency hospital. After being treated with the medications prescribed below, my colleague has now fully recovered. There is currently much debate and experimentation on the type of medications that might effectively inhibit and/or alleviate the symptoms of COVID-19. I have recently obtained a picture from my recovered colleague, which shows the medications that were used for COVID-19 treatment at a Wuhan hospital.
The three medications, from top to bottom are:
a) Lianhua Qingwen Jiaonang (LQF Caplets)
b) Arbidol Hydrochloride Tablets
c) Moxifloxacin Hydrochloride Tablets
A short description follows:
Lianhua Qingwen Jiaonang: Lianhua-Qingwen Formula (LQF) is used for the prevention and treatment of viral influenza in China.
Arbidol Hydrochloride: Arbidol (active ingredient: Umifenovir) is an antiviral for influenza, developed in the Soviet Union in 1974. It is available over-the-counter in Russia. Arbidol (Russian: Арбидол and Chinese: 阿比朵尔) is also manufactured in China . It is not FDA approved (Food and Drug Administration is a US federal agency), but it is currently being evaluated by WHO (World Health Organisation).
Moxifloxacin Hydrochloride: An FDA approved medicine, used as a treatment for bacterial infections sinusitis and chronic bronchitis amongst others.
I am not a medical expert, but I offer this information purely to inform and not in any way to recommend. That is for the medical profession, scientists and experts of WHO and the FDA.
© 2020 Dr Robert Frew. All rights reserved